Ann: Cellmid Receives First Order From Chinese Distributor, page-18

It is obvious that investors are not impressed with substantial growth forecast on T7 picture cartoon neither were they convinced with revenue forecast on China nor with the report. The SP stays as it was.
I personally cannot blame them. I am as dissapointed as they are. How on earth can a manufacturing and retail company have salaries and administrative costs at 91 percent of total revenue and expect to make money?
What happened to the European and Korean arms of the business? What have they done with the test kits?
The report is selective and only tells what they want you to hear.